Recent strategies and progress in identifying host factors involved in virus replication

Current Opinion in Microbiology

Volumn 26, Issue , 2015, Pages 79-88

  König, Renate ^a,b,c   Stertz, Silke ^d  

^a PAUL EHRLICH INSTITUT   (Germany)

^b BURNHAM INSTITUTE   (United States)

^c German Center for Infection Research (DZIF)   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOPHILIN A; HOST FACTOR; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VIRUS PROTEIN; PROTEOME;

ANTIVIRAL ACTIVITY; CELL LINE; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; LENTIVIRINAE; NONHUMAN; NUCLEAR IMPORT; REVIEW; RNA INTERFERENCE; SCREENING TEST; SYSTEMS BIOLOGY; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS UNCOATING; ANIMAL; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; VIRUS;

ANIMALS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEOME; SYSTEMS BIOLOGY; VIRUS REPLICATION; VIRUSES;

EID: 84934967613     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2015.06.001     Document Type: Review

References (104)

1. Nurse P., Hayles J. The cell in an era of systems biology. Cell 2011, 144:850-854.
2. Konig R., Stertz S., Zhou Y., Inoue A., Hoffmann H.H., Bhattacharyya S., Alamares J.G., Tscherne D.M., Ortigoza M.B., Liang Y., et al. Human host factors required for influenza virus replication. Nature 2010, 463:813-817.
3. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
4. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., Becker D., Khalil H., Ogilvie L.A., Hess S., et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
5. Ward S.E., Kim H.S., Komurov K., Mendiratta S., Tsai P.L., Schmolke M., Satterly N., Manicassamy B., Forst C.V., Roth M.G., et al. Host modulators of H1N1 cytopathogenicity. PLoS ONE 2012, 7:e39284.
6. Su W.C., Chen Y.C., Tseng C.H., Hsu P.W., Tung K.F., Jeng K.S., Lai M.M. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A 2013, 110:17516-17521.
7. Tran A.T., Rahim M.N., Ranadheera C., Kroeker A., Cortens J.P., Opanubi K.J., Wilkins J.A., Coombs K.M. Knockdown of specific host factors protects against influenza virus-induced cell death. Cell Death Dis 2013, 4:e769.
8. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60.
9. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
10. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4:495-504.
11. Genovesio A., Kwon Y.J., Windisch M.P., Kim N.Y., Choi S.Y., Kim H.C., Jung S., Mammano F., Perrin V., Boese A.S., et al. Automated genome-wide visual profiling of cellular proteins involved in HIV infection. J Biomol Screen 2011, 16:945-958.
12. Yeung M.L., Houzet L., Yedavalli V.S., Jeang K.T. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 2009, 284:19463-19473.
13. Jager S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., et al. Global landscape of HIV-human protein complexes. Nature 2012, 481:365-370.
14. Davis Z.H., Verschueren E., Jang G.M., Kleffman K., Johnson J.R., Park J., Von Dollen J., Maher M.C., Johnson T., Newton W., et al. Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes. Mol Cell 2015, 57:349-360.
15. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta P.B., Hao T., Silver S.J., Root D.E., et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139:1255-1267.
16. Watanabe T., Kawakami E., Shoemaker J.E., Lopes T.J., Matsuoka Y., Tomita Y., Kozuka-Hata H., Gorai T., Kuwahara T., Takeda E., et al. Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe 2014, 16:795-805.
17. Ramage H.R., Kumar G.R., Verschueren E., Johnson J.R., Von Dollen J., Johnson T., Newton B., Shah P., Horner J., Krogan N.J., et al. A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay. Mol Cell 2015, 57:329-340.
18. Pichlmair A., Kandasamy K., Alvisi G., Mulhern O., Sacco R., Habjan M., Binder M., Stefanovic A., Eberle C.A., Goncalves A., et al. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 2012, 487:486-490.
19. Schoggins J.W., MacDuff D.A., Imanaka N., Gainey M.D., Shrestha B., Eitson J.L., Mar K.B., Richardson R.B., Ratushny A.V., Litvak V., et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 2014, 505:691-695.
20. Lee M.N., Roy M., Ong S.E., Mertins P., Villani A.C., Li W., Dotiwala F., Sen J., Doench J.G., Orzalli M.H., et al. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat Immunol 2013, 14:179-185.
21. Chevrier N., Mertins P., Artyomov M.N., Shalek A.K., Iannacone M., Ciaccio M.F., Gat-Viks I., Tonti E., DeGrace M.M., Clauser K.R., et al. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 2011, 147:853-867.
22. Chiang C.Y., Engel A., Opaluch A.M., Ramos I., Maestre A.M., Secundino I., De Jesus P.D., Nguyen Q.T., Welch G., Bonamy G.M., et al. Cofactors required for TLR7- and TLR9-dependent innate immune responses. Cell Host Microbe 2012, 11:306-318.
23. Li S., Wang L., Berman M., Kong Y.Y., Dorf M.E. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 2011, 35:426-440.
24. Mahon C., Krogan N.J., Craik C.S., Pick E. Cullin E3 ligases and their rewiring by viral factors. Biomolecules 2014, 4:897-930.
25. Salomon D., Orth K. What pathogens have taught us about posttranslational modifications. Cell Host Microbe 2013, 14:269-279.
26. Wojcechowskyj J.A., Didigu C.A., Lee J.Y., Parrish N.F., Sinha R., Hahn B.H., Bushman F.D., Jensen S.T., Seeholzer S.H., Doms R.W. Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry. Cell Host Microbe 2013, 13:613-623.
27. Pohl M.O., Edinger T.O., Stertz S. Prolidase is required for early trafficking events during influenza A virus entry. J Virol 2014, 88:11271-11283.
28. He J., Sun E., Bujny M.V., Kim D., Davidson M.W., Zhuang X. Dual function of CD81 in influenza virus uncoating and budding. PLoS Pathog 2013, 9:e1003701.
29. Shaw M.L., Stone K.L., Colangelo C.M., Gulcicek E.E., Palese P. Cellular proteins in influenza virus particles. PLoS Pathog 2008, 4:e1000085.
30. Banerjee I., Miyake Y., Nobs S.P., Schneider C., Horvath P., Kopf M., Matthias P., Helenius A., Yamauchi Y. Influenza: a virus uses the aggresome processing machinery for host cell entry. Science 2014, 346:473-477.
31. Yamauchi Y., Boukari H., Banerjee I., Sbalzarini I.F., Horvath P., Helenius A. Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry. PLoS Pathog 2011, 7:e1002316.
32. Huang I.C., Bailey C.C., Weyer J.L., Radoshitzky S.R., Becker M.M., Chiang J.J., Brass A.L., Ahmed A.A., Chi X., Dong L., et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 2011, 7:e1001258.
33. Mudhasani R., Tran J.P., Retterer C., Radoshitzky S.R., Kota K.P., Altamura L.A., Smith J.M., Packard B.Z., Kuhn J.H., Costantino J., et al. IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 2013, 87:8451-8464.
34. Lu J., Pan Q., Rong L., He W., Liu S.L., Liang C. The IFITM proteins inhibit HIV-1 infection. J Virol 2011, 85:2126-2137.
35. Anafu A.A., Bowen C.H., Chin C.R., Brass A.L., Holm G.H. Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem 2013, 288:17261-17271.
36. Feeley E.M., Sims J.S., John S.P., Chin C.R., Pertel T., Chen L.M., Gaiha G.D., Ryan B.J., Donis R.O., Elledge S.J., et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 2011, 7:e1002337.
37. Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484:519-523.
38. Benfield C., Smith S.E., Wright E., Wash R.S., Ferrara F., Temperton N.J., Kellam P. Bat and pig interferon-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses. J Gen Virol 2015, (Epub ahead of print).
39. Smith S.E., Gibson M.S., Wash R.S., Ferrara F., Wright E., Temperton N., Kellam P., Fife M. Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro. J Virol 2013, 87:12957-12966.
40. Lanz C., Yanguez E., Andenmatten D., Stertz S. Swine interferon-inducible transmembrane proteins potently inhibit influenza A virus replication. J Virol 2015, 89:863-869.
41. Desai T.M., Marin M., Chin C.R., Savidis G., Brass A.L., Melikyan G.B. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog 2014, 10:e1004048.
42. Bailey C.C., Zhong G., Huang I.C., Farzan M. IFITM-family proteins: the cell's first line of antiviral defense. Annu Rev Virol 2014, 1:261-283.
43. Amini-Bavil-Olyaee S., Choi Y.J., Lee J.H., Shi M., Huang I.C., Farzan M., Jung J.U. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013, 13:452-464.
44. Compton A.A., Bruel T., Porrot F., Mallet A., Sachse M., Euvrard M., Liang C., Casartelli N., Schwartz O. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. Cell Host Microbe 2014, 16:736-747.
45. Tartour K., Appourchaux R., Gaillard J., Nguyen X.N., Durand S., Turpin J., Beaumont E., Roch E., Berger G., Mahieux R., et al. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 2014, 11:103.
46. Zhang Y.H., Zhao Y., Li N., Peng Y.C., Giannoulatou E., Jin R.H., Yan H.P., Wu H., Liu J.H., Liu N., et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 2013, 4:1418.
47. Mills T.C., Rautanen A., Elliott K.S., Parks T., Naranbhai V., Ieven M.M., Butler C.C., Little P., Verheij T., Garrard C.S., et al. IFITM3 and susceptibility to respiratory viral infections in the community. J Infect Dis 2014, 209:1028-1031.
48. Williams D.E., Wu W.L., Grotefend C.R., Radic V., Chung C., Chung Y.H., Farzan M., Huang I.C. IFITM3 polymorphism rs12252-C restricts influenza A viruses. PLOS ONE 2014, 9:e110096.
49. Christ F., Thys W., De Rijck J., Gijsbers R., Albanese A., Arosio D., Emiliani S., Rain J.C., Benarous R., Cereseto A., et al. Transportin-SR2 imports HIV into the nucleus. Curr Biol 2008, 18:1192-1202.
50. Hilditch L., Towers G.J. A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr Opin Virol 2014, 4:32-36.
51. De Iaco A., Santoni F., Vannier A., Guipponi M., Antonarakis S., Luban J. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology 2013, 10:20.
52. Di Nunzio F., Fricke T., Miccio A., Valle-Casuso J.C., Perez P., Souque P., Rizzi E., Severgnini M., Mavilio F., Charneau P., et al. Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology 2013, 440:8-18.
53. Ocwieja K.E., Brady T.L., Ronen K., Huegel A., Roth S.L., Schaller T., James L.C., Towers G.J., Young J.A., Chanda S.K., et al. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog 2011, 7:e1001313.
54. Schaller T., Ocwieja K.E., Rasaiyaah J., Price A.J., Brady T.L., Roth S.L., Hue S., Fletcher A.J., Lee K., KewalRamani V.N., et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 2011, 7:e1002439.
55. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
56. Lee K., Ambrose Z., Martin T.D., Oztop I., Mulky A., Julias J.G., Vandegraaff N., Baumann J.G., Wang R., Yuen W., et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7:221-233.
57. Price A.J., Fletcher A.J., Schaller T., Elliott T., Lee K., KewalRamani V.N., Chin J.W., Towers G.J., James L.C. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog 2012, 8:e1002896.
58. Kataoka N., Bachorik J.L., Dreyfuss G. Transportin-SR: a nuclear import receptor for SR proteins. J Cell Biol 1999, 145:1145-1152.
59. Rasaiyaah J., Tan C.P., Fletcher A.J., Price A.J., Blondeau C., Hilditch L., Jacques D.A., Selwood D.L., James L.C., Noursadeghi M., et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503:402-405.
60. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
61. Goff S.P. HIV: slipping under the radar. Nature 2013, 503:352-353.
62. Ambrose Z., Aiken C. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. Virology 2014, 454-455:371-379.
63. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
64. Goujon C., Moncorge O., Bauby H., Doyle T., Ward C.C., Schaller T., Hue S., Barclay W.S., Schulz R., Malim M.H. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013, 502:559-562.
65. Liu Z., Pan Q., Ding S., Qian J., Xu F., Zhou J., Cen S., Guo F., Liang C. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013, 14:398-410.
66. Kane M., Yadav S.S., Bitzegeio J., Kutluay S.B., Zang T., Wilson S.J., Schoggins J.W., Rice C.M., Yamashita M., Hatziioannou T., et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013, 502:563-566.
67. Fackler O.T., Keppler O.T. MxB/Mx2: the latest piece in HIV's interferon puzzle. EMBO Rep 2013, 14:1028-1029.
68. Melen K., Keskinen P., Ronni T., Saveneva T., Lounatmaa K., Julkunen I. Human MxB protein, an interferon-a-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J Biol Chem 1996, 271:23478-23486.
69. Matreyek K.A., Wang W., Serrao E., Singh P., Levin H.L., Engelman A. Host and viral determinants for MxB restriction of HIV-1 infection. Retrovirology 2014, 11:90.
70. Stertz S., Shaw M.L. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect 2011, 13:516-525.
71. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., Konig R., et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 2009, 5:e1000437.
72. Watanabe T., Watanabe S., Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7:427-439.
73. Pache L., Konig R., Chanda S.K. Identifying HIV-1 host cell factors by genome-scale RNAi screening. Methods 2011, 53:3-12.
74. Conlon J., Burdette D.L., Sharma S., Bhat N., Thompson M., Jiang Z., Rathinam V.A., Monks B., Jin T., Xiao T.S., et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol 2013, 190:5216-5225.
75. Varble A., Benitez A.A., Schmid S., Sachs D., Shim J.V., Rodriguez-Barrueco R., Panis M., Crumiller M., Silva J.M., Sachidanandam R., et al. An in vivo RNAi screening approach to identify host determinants of virus replication. Cell Host Microbe 2013, 14:346-356.
76. Wang T., Wei J.J., Sabatini D.M., Lander E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 2014, 343:80-84.
77. Shalem O., Sanjana N.E., Hartenian E., Shi X., Scott D.A., Mikkelsen T.S., Heckl D., Ebert B.L., Root D.E., Doench J.G., et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014, 343:84-87.
78. Zhou Y., Zhu S., Cai C., Yuan P., Li C., Huang Y., Wei W. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 2014, 509:487-491.
79. Sander J.D., Joung J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 2014, 32:347-355.
80. Chen B., Gilbert L.A., Cimini B.A., Schnitzbauer J., Zhang W., Li G.W., Park J., Blackburn E.H., Weissman J.S., Qi L.S., et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 2013, 155:1479-1491.
81. Hao L., Sakurai A., Watanabe T., Sorensen E., Nidom C.A., Newton M.A., Ahlquist P., Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454:890-893.
82. Sui B., Bamba D., Weng K., Ung H., Chang S., Van Dyke J., Goldblatt M., Duan R., Kinch M.S., Li W.B. The use of random homozygous gene perturbation to identify novel host-oriented targets for influenza. Virology 2009, 387:473-481.
83. Nguyen D.G., Wolff K.C., Yin H., Caldwell J.S., Kuhen K.L. "UnPAKing" human immunodeficiency virus (HIV) replication: using small interfering RNA screening to identify novel cofactors and elucidate the role of group I PAKs in HIV infection. J Virol 2006, 80:130-137.
84. Liu L., Oliveira N.M., Cheney K.M., Pade C., Dreja H., Bergin A.M., Borgdorff V., Beach D.H., Bishop C.L., Dittmar M.T., et al. A whole genome screen for HIV restriction factors. Retrovirology 2011, 8:94.
85. Nguyen D.G., Yin H., Zhou Y., Wolff K.C., Kuhen K.L., Caldwell J.S. Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening. Virology 2007, 362:16-25.
86. Tai A.W., Benita Y., Peng L.F., Kim S.S., Sakamoto N., Xavier R.J., Chung R.T. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009, 5:298-307.
87. Li Q., Brass A.L., Ng A., Hu Z., Xavier R.J., Liang T.J., Elledge S.J. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A 2009, 106:16410-16415.
88. Sessions O.M., Barrows N.J., Souza-Neto J.A., Robinson T.J., Hershey C.L., Rodgers M.A., Ramirez J.L., Dimopoulos G., Yang P.L., Pearson J.L., et al. Discovery of insect and human dengue virus host factors. Nature 2009, 458:1047-1050.
89. Krishnan M.N., Ng A., Sukumaran B., Gilfoy F.D., Uchil P.D., Sultana H., Brass A.L., Adametz R., Tsui M., Qian F., et al. RNA interference screen for human genes associated with West Nile virus infection. Nature 2008, 455:242-245.
90. Uetz P., Dong Y.A., Zeretzke C., Atzler C., Baiker A., Berger B., Rajagopala S.V., Roupelieva M., Rose D., Fossum E., et al. Herpesviral protein networks and their interaction with the human proteome. Science 2006, 311:239-242.
91. Liu S.Y., Sanchez D.J., Aliyari R., Lu S., Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A 2012, 109:4239-4244.
92. Fusco D.N., Brisac C., John S.P., Huang Y.W., Chin C.R., Xie T., Zhao H., Jilg N., Zhang L., Chevaliez S., et al. A genetic screen identifies interferon-alpha effector genes required to suppress hepatitis C virus replication. Gastroenterology 2013, 144. 1438-1449, 1449, 1431-1439.
93. Zhao H., Lin W., Kumthip K., Cheng D., Fusco D.N., Hofmann O., Jilg N., Tai A.W., Goto K., Zhang L., et al. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus. J Hepatol 2012, 56:326-333.
94. Rozenblatt-Rosen O., Deo R.C., Padi M., Adelmant G., Calderwood M.A., Rolland T., Grace M., Dricot A., Askenazi M., Tavares M., et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012, 487:491-495.
95. Pickett B.E., Sadat E.L., Zhang Y., Noronha J.M., Squires R.B., Hunt V., Liu M., Kumar S., Zaremba S., Gu Z., et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res 2012, 40:D593-D598.
96. Chatr-aryamontri A., Ceol A., Peluso D., Nardozza A., Panni S., Sacco F., Tinti M., Smolyar A., Castagnoli L., Vidal M., et al. VirusMINT: a viral protein interaction database. Nucleic Acids Res 2009, 37:D669-D673.
97. Bushman F.D., Barton S., Bailey A., Greig C., Malani N., Bandyopadhyay S., Young J., Chanda S., Krogan N. Bringing it all together: big data and HIV research. AIDS 2013, 27:835-838.
98. Fahey M.E., Bennett M.J., Mahon C., Jager S., Pache L., Kumar D., Shapiro A., Rao K., Chanda S.K., Craik C.S., et al. GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics 2011, 12:298.
99. Fu W., Sanders-Beer B.E., Katz K.S., Maglott D.R., Pruitt K.D., Ptak R.G. Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res 2009, 37:D417-D422.
100. Ptak R.G., Fu W., Sanders-Beer B.E., Dickerson J.E., Pinney J.W., Robertson D.L., Rozanov M.N., Katz K.S., Maglott D.R., Pruitt K.D., et al. Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses 2008, 24:1497-1502.
101. Pinney J.W., Dickerson J.E., Fu W., Sanders-Beer B.E., Ptak R.G., Robertson D.L. HIV-host interactions: a map of viral perturbation of the host system. AIDS 2009, 23:549-554.
102. Aderem A., Adkins J.N., Ansong C., Galagan J., Kaiser S., Korth M.J., Law G.L., McDermott J.G., Proll S.C., Rosenberger C., et al. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. mBio 2011, 2:e00310-e00325.
103. Squires R.B., Noronha J., Hunt V., Garcia-Sastre A., Macken C., Baumgarth N., Suarez D., Pickett B.E., Zhang Y., Larsen C.N., et al. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses 2012, 6:404-416.
104. Matsuoka Y., Matsumae H., Katoh M., Eisfeld A.J., Neumann G., Hase T., Ghosh S., Shoemaker J.E., Lopes T.J., Watanabe T., et al. A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol 2013, 7:97.